Inventor
Emiliano TAMANINI
Inventor
GB
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
C07BGeneral methods of organic chemistry10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
12,202,828Bicyclic heterocycle compounds and their uses in therapy202512,071,429Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity202411,866,428Bicyclic heterocycle compounds and their uses in therapy202411,643,410Bicyclic heterocycle compounds and their uses in therapy202311,261,171Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity202211,225,476Bicyclic heterocycle compounds and their uses in therapy2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ASTEX THERAPEUTICS LTD (6)· patent assignee history
2022–2024Patents assigned to CANCER RESEARCH TECH LTD (2)· patent assignee history
2022–2025Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASTEX THERAPEUTICS LTD | 6 | 2022–2025 |
| CANCER RESEARCH TECH LTD | 2 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 6 | 2022–2025 |